Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Behavioral and neurophysiological correlates of striatal dopamine depletion: a rodent model of Parkinson's disease.

Plowman EK, Kleim JA.

J Commun Disord. 2011 Sep-Oct;44(5):549-56. doi: 10.1016/j.jcomdis.2011.04.008. Epub 2011 Apr 30. Review.

2.

alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach.

Bazzu G, Calia G, Puggioni G, Spissu Y, Rocchitta G, Debetto P, Grigoletto J, Zusso M, Migheli R, Serra PA, Desole MS, Miele E.

CNS Neurol Disord Drug Targets. 2010 Aug;9(4):482-90. Review.

PMID:
20522009
3.

The interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesias.

Lieu CA, Subramanian T.

Brain Res Bull. 2012 Jan 4;87(1):1-9. doi: 10.1016/j.brainresbull.2011.09.013. Epub 2011 Sep 24. Review.

4.

Striatal synaptic plasticity: implications for motor learning and Parkinson's disease.

Pisani A, Centonze D, Bernardi G, Calabresi P.

Mov Disord. 2005 Apr;20(4):395-402. Review.

PMID:
15719415
5.

The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.

Prediger RD, Aguiar AS Jr, Moreira EL, Matheus FC, Castro AA, Walz R, De Bem AF, Latini A, Tasca CI, Farina M, Raisman-Vozari R.

Curr Pharm Des. 2011;17(5):489-507. Review.

PMID:
21375482
6.

A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry.

Zgaljardic DJ, Borod JC, Foldi NS, Mattis P.

Cogn Behav Neurol. 2003 Dec;16(4):193-210. Review.

PMID:
14665819
7.

Striatal mechanisms in Parkinson's disease: new insights from computer modeling.

K├Âtter R, Wickens J.

Artif Intell Med. 1998 May;13(1-2):37-55. Review.

PMID:
9654378
8.

The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.

Jenner P, Marsden CD.

J Neural Transm Suppl. 1986;20:11-39. Review.

PMID:
3091760
9.

Behavioral analysis of motor and non-motor symptoms in rodent models of Parkinson's disease.

Dunnett SB, Lelos M.

Prog Brain Res. 2010;184:35-51. doi: 10.1016/S0079-6123(10)84003-8. Review.

PMID:
20887869
10.

What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?

Magnard R, Vachez Y, Carcenac C, Krack P, David O, Savasta M, Boulet S, Carnicella S.

Transl Psychiatry. 2016 Mar 8;6:e753. doi: 10.1038/tp.2016.17. Review.

11.

Synaptic dysfunction in Parkinson's disease.

Picconi B, Piccoli G, Calabresi P.

Adv Exp Med Biol. 2012;970:553-72. doi: 10.1007/978-3-7091-0932-8_24. Review.

PMID:
22351072
12.

Striatal molecular mechanisms and motor dysfunction in Parkinson's disease.

Chase TN, Konitsiotis S, Oh JD.

Adv Neurol. 2001;86:355-60. Review. No abstract available.

PMID:
11553996
13.

Dopamine-mediated gene regulation in models of Parkinson's disease.

Gerfen CR.

Ann Neurol. 2000 Apr;47(4 Suppl 1):S42-50; discussion S50-2. Review.

PMID:
10762131
14.

[The neuropsychology of nigrostriatal dopaminergic transmission in Parkinson's disease].

Wallesch C.

Fortschr Neurol Psychiatr. 2011 Dec;79(12):692-5. doi: 10.1055/s-0031-1281596. Epub 2011 Oct 18. Review. German.

PMID:
22009273
15.

Limb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training.

Ciucci MR, Ma ST, Kane JR, Ahrens AM, Schallert T.

Parkinsonism Relat Disord. 2008;14 Suppl 2:S172-5. doi: 10.1016/j.parkreldis.2008.04.027. Epub 2008 Jun 27. Review.

16.

Frontal-striatal circuit functions: context, sequence, and consequence.

Saint-Cyr JA.

J Int Neuropsychol Soc. 2003 Jan;9(1):103-27. Review. Erratum in: J Int Neuropsychol Soc. 2003 Mar;9(3):502..

PMID:
12570364
17.

Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry.

Owen AM.

Neuroscientist. 2004 Dec;10(6):525-37. Review.

PMID:
15534038
18.

Behavioral models of Parkinson's disease in rodents: a new look at an old problem.

Meredith GE, Kang UJ.

Mov Disord. 2006 Oct;21(10):1595-606. Review.

PMID:
16830310
19.

Aberrant dopamine transmission and cognitive dysfunction in animal models of Parkinson's disease.

Lelos MJ, Dunnett SB.

J Parkinsons Dis. 2011;1(2):151-65. doi: 10.3233/JPD-2011-11036. Review.

PMID:
23934917
20.

Mechanism of action of dopaminergic agents in Parkinson's disease.

Koller WC, Rueda MG.

Neurology. 1998 Jun;50(6 Suppl 6):S11-4; discussion S44-8. Review.

PMID:
9633680

Supplemental Content

Support Center